Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kami Maddocks

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2020
Novel targets in aggressive lymphomaKami Maddocks
Blood|August 29, 2024
BTKi is better: a lesson learned?Kami Maddocks
Blood|November 10, 2018
Chemotherapy-free induction in MCL: ready for prime time?Kami Maddocks
Blood|February 18, 2021
Building on BTK inhibition in MCLKami Maddocks
Blood|August 30, 2018
Update on mantle cell lymphomaKami Maddocks
The Lancet. Oncology|May 14, 2021
The era of CD19-directed therapy in diffuse large B-cell lymphomaKami Maddocks
The Lancet. Haematology|November 26, 2021
Follicular lymphoma: is more better or is less really more?Kami Maddocks
Journal of Hematology & Oncology|July 27, 2019
Novel and emerging therapies for B cell lymphomaSabarish Ayyappan, Kami Maddocks
Lancet (London, England)|May 5, 2024
Does TRIANGLE take down transplantation in mantle cell lymphoma?Peter Martin, Kami Maddocks
Hematology. American Society of Hematology. Education Program|December 7, 2024
Your chemo is no good here: management of high-risk MCLYazeed Sawalha, Kami Maddocks
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Hematology. American Society of Hematology. Education Program|December 4, 2020
Novel targets in aggressive lymphomaKami Maddocks
Blood|August 29, 2024
BTKi is better: a lesson learned?Kami Maddocks
Blood|November 10, 2018
Chemotherapy-free induction in MCL: ready for prime time?Kami Maddocks
Blood|February 18, 2021
Building on BTK inhibition in MCLKami Maddocks
Blood|August 30, 2018
Update on mantle cell lymphomaKami Maddocks
The Lancet. Oncology|May 14, 2021
The era of CD19-directed therapy in diffuse large B-cell lymphomaKami Maddocks
The Lancet. Haematology|November 26, 2021
Follicular lymphoma: is more better or is less really more?Kami Maddocks
Journal of Hematology & Oncology|July 27, 2019
Novel and emerging therapies for B cell lymphomaSabarish Ayyappan, Kami Maddocks
Lancet (London, England)|May 5, 2024
Does TRIANGLE take down transplantation in mantle cell lymphoma?Peter Martin, Kami Maddocks
Hematology. American Society of Hematology. Education Program|December 7, 2024
Your chemo is no good here: management of high-risk MCLYazeed Sawalha, Kami Maddocks
Pageof 10